查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
蛋白质体学市场：产业趋势与全球预测（~2035）- 依产品类型、仪器/技术类型、试剂盒/试剂类型、蛋白质体学服务类型、应用领域、最终用户、地区
市场调查报告书
商品编码
1534567

蛋白质体学市场：产业趋势与全球预测（~2035）- 依产品类型、仪器/技术类型、试剂盒/试剂类型、蛋白质体学服务类型、应用领域、最终用户、地区

Proteomics Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Offering, Type of Instrument / Technology, Type of Kit and Reagent, Type of Proteomics Service, Application Area, End User and Geography
出版日期: | 出版商: Roots Analysis | 英文 210 Pages | 商品交期: 最快1-2个工作天内

价格

蛋白质体学市场规模估计到2024年将达到 316亿美元，2024-2035年预测期间年复合成长率为 10.5%。

自 1987年发现第一个人类基因图谱以来，基于组学的分析领域取得了巨大进展。基于组学的分析目的是识别、描述和量化细胞内生物分子的大规模集合。尖端组学技术包括基因组学、蛋白质组学、转录组学和代谢组学。基因组学的成功为蛋白质组学的进步铺平了道路。蛋白质体学已成为在分子层面上了解疾病的极其重要的研究领域。

蛋白质体学是对细胞、组织和生物体中蛋白质的大规模分析，以了解它们的结构、功能和相互作用。该技术透过分析细胞表达的整个蛋白质范围，提供对细胞和组织内动态过程的深入了解。蛋白质体学利用质谱、晶体学、蛋白质微阵列和生物资讯学等先进技术来分析和量化蛋白质，提供细胞功能的全面视图。蛋白质体学的应用导致了用于疾病早期诊断的新型生物标记的鑑定、标靶候选药物的开发以及对抗药性机制的全面了解。蛋白质体学具有阐明复杂生物过程和疾病机制的潜力，使其成为生物医学研究和医疗保健的宝贵工具。

蛋白质体学解决方案提供者将其专有技术扩展到多元化的客户群，包括生物製药公司、学术研究中心和研究机构，以充分利用这个快速发展的市场中的成长机会。製药公司将先进的高通量技术和多组学方法纳入其蛋白质体学工作流程，以提高蛋白质分析的灵敏度、准确性和速度。单细胞蛋白质体学、太空蛋白质体学和先进成像技术等新兴技术用来破解复杂的细胞异质性和疾病机制。此外，人工智慧和机器学习演算法的出现彻底改变了资料分析，实现了预测建模并加速了新生物标记的发现。随着蛋白质体学解决方案的采用不断增加以及该领域的技术创新不断发生，预计蛋白质体学市场的成长机会将在预测期内持续存在。

本报告研究了全球蛋白质体学市场，提供市场概述，依产品类型、仪器/技术类型、试剂盒/试剂类型、蛋白质组学服务类型、应用领域、最终用户和地区的趋势，以及进入市场的公司概况等。

目录

第1章 研究方法

第2章 经济与其他专案特定考量

第3章 执行摘要

第4章 简介

  • 蛋白质体学概述
  • 蛋白质体学过程包括的步骤
  • 蛋白质体学的类型
  • 蛋白质体学的应用
  • 蛋白质体学领域的挑战
  • 蛋白质体学领域的最新趋势

第5章 市场影响分析：驱动因素、限制、机会、挑战

第6章 全球蛋白质体学市场

第7章 蛋白质体市场（依产品类型）

第8章 蛋白质体学市场（依设备/技术类型）

第9章 蛋白质体学市场（依试剂盒/试剂类型）

第10章 蛋白质体学市场（依蛋白质体学服务类型）

第11章 蛋白质体学市场（依应用领域）

第12章 蛋白质体学市场（依最终用户）

第13章 蛋白质体市场（依地区）

第14章 市场情势：主要蛋白质体学解决方案提供者

第15章 企业竞争力分析：主要蛋白质体学解决方案提供者

第16章 公司简介：总部位于北美的蛋白质体学解决方案提供者

  • Agilent Technologies
  • Bruker
  • Creative Biolabs
  • Nautilus Biotechnology
  • PerkinElmer
  • Seer
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • CellCarta
  • Creative Proteomics
  • Cytiva
  • Promega
  • SCIEX
  • SomaLogic
  • Key Winning Strategies

第17章 公司简介：总部位于欧洲的蛋白质体学解决方案提供者

  • Merck
  • Olink
  • Promise Proteomics
  • Proteome Factory
  • Proteome Sciences
  • Key Winning Strategies

第18章 公司简介：总部位于亚太地区的蛋白质体学解决方案提供者

  • Proteomics International
  • Macrogen
  • Allele Life Sciences
  • Bertis
  • BGI Genomics
  • VProteomics
  • Key Winning Strategies

第19章 蛋白质体学市场：大趋势分析

第20章 价值链分析

第21章 高阶主管洞察力

第22章 附录 1：表格资料

第23章 附录2：公司与组织名单

Product Code: RA100501

The Proteomics Market is valued at USD 31.6 billion in 2024 growing at a CAGR of 10.5% during the forecast period 2024-2035.

The field of omics-based analysis has undergone significant advancements since the discovery of the first human genetic map in 1987. Omics-based analysis aims to identify, describe, and quantify large sets of biological molecules within a cell. The most advanced omics technologies include genomics, proteomics, transcriptomics, and metabolomics. The success of genomics has paved the way for advancements in proteomics, which has become a crucial area of research in understanding diseases at a molecular level.

Proteomics is the large-scale analysis of proteins in a cell, tissue, or organism to understand their structure, function, and interactions. This technology offers deeper insights into the dynamic processes within cells and tissues by analyzing the entire set of proteins expressed by the cell. Proteomics employs advanced technologies such as mass spectrometry, crystallography, protein microarrays, and bioinformatics to analyze and quantify proteins, providing a comprehensive view of cellular functions. The application of proteomics has led to the identification of novel biomarkers for early disease diagnosis, development of targeted drug candidates, and a holistic understanding of drug resistance mechanisms. Proteomics has the potential to unravel the complexities of biological processes and disease mechanisms, making it a valuable tool in biomedical research and healthcare.

To capitalize on the growing opportunity in this rapidly evolving market, proteomics solution providers are improving the penetration of their proprietary technologies within diverse client bases, including biopharma companies, academic research centers, and research institutes. Pharmaceutical companies are integrating advanced high-throughput technologies and multi-omics approaches into their proteomics workflow to enhance sensitivity, accuracy, and speed of protein analysis. Emerging technologies such as single-cell proteomics, spatial proteomics, and advanced imaging techniques are being leveraged to decode complex cellular heterogeneity and disease mechanisms. Additionally, the advent of artificial intelligence and machine learning algorithms is transforming data analysis, enabling predictive modeling, and accelerating the discovery of novel biomarkers As the adoption of proteomics solutions continues to rise and innovation in this domain remains continuous, we expect the opportunity for proteomics market growth to be sustained over the forecast period.

Key Market Segments

Type of Offering

  • Instruments
  • Kits and Reagents
  • Proteomics Services

Type of Instrument / Technology

  • Chromatography (Affinity, High -performance Liquid Chromatography, Ion and Supercritical Fluid)
  • Electrophoresis (Capillary and Gel Electrophoresis)
  • Protein Microarray (Macroarrays and Microchips)
  • Spectrometry (Circular Dichroism, Mass Spectroscopy and Nuclear Magnetic Resonance)
  • Surface Plasmon Resonance
  • X-ray Crystallography
  • Other Technologies

Type of Kit and Reagent

  • Chromatography Reagents
  • Electrophoresis Reagents
  • Immunoassay Reagents
  • Protein Microarray Reagents
  • Spectroscopy Reagents,
  • X-ray Crystallography Reagents
  • Other Reagents

Type of Proteomics Service

  • Bioinformatics Services
  • Core Proteomics Services

Application Area

  • Diagnostics
  • Research (Drug Discovery, and Basic and Translational Research)
  • Other Applications

End User

  • Academic and Research Institutes
  • Clinical Laboratories and Hospitals
  • Pharmaceutical and Biotechnology Companies
  • Other End users

Geography

  • North America (US, Canada and Rest of North America)
  • Europe (France, Germany, Italy, Spain, UK and Rest of Europe)
  • Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and North Africa (Israel and Rest of Middle East and North Africa)
  • Rest of the World (South Africa and Rest of the World)

Research Coverage:

  • This chapter provides an introductory overview of proteomics, covering the fundamental workflow, various types of proteomics, and its diverse applications. The discussion also highlights the challenges and limitations associated with proteomics. Additionally, the chapter explores the current trends and advancements in the field of proteomics, providing a comprehensive understanding of this rapidly evolving domain.
  • A thorough examination of the market for proteomics is presented, encompassing a comprehensive analysis of the factors that may impact its growth. This includes an identification and discussion of key drivers, potential restraints, emerging opportunities, and existing challenges.
  • A detailed market analysis is presented, providing an informed estimate of the current market size and future growth potential of the proteomics market over the next decade. This assessment is based on an examination of multiple parameters, including likely adoption trends and validated through secondary and primary research. The report also includes a breakdown of the current and forecasted market opportunity within the proteomics industry, with a focus on the likely distribution of this opportunity. To ensure accuracy and account for potential uncertainties, three forecast scenarios are presented: conservative, base, and optimistic scenarios, which represent different potential tracks of market growth till 2035.
  • Comprehensive projections of the current and future opportunity within proteomics market across different types of offering, such as instruments / technologies, kits and reagents, and proteomics services.
  • Comprehensive projections of the current and future opportunity within proteomics domain across various types of instruments / technologies, such as chromatography, electrophoresis, protein microarray, spectrometry, surface plasmon resonance, X-ray crystallography, and other technologies.
  • Detailed predictions of the current and future opportunity within proteomics industry across various types of kits and reagents, such as chromatography reagents, electrophoresis reagents, immunoassay, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents and other reagents.
  • Comprehensive predictions of the current and future opportunity within proteomics market across different types of proteomics services, such as bioinformatics services and core proteomics services.
  • Comprehensive projections of the current and future opportunity within proteomics industry across various application areas, such as diagnostics, research and other applications.
  • Detailed predictions of the current and future opportunity within proteomics market across different end users, such as academic and research institutes, clinical laboratories and hospitals, pharmaceutical and biotechnology companies and other end users.
  • Comprehensive predictions of the current and future opportunity within proteomics industry across various geographies, such as North America (US, Canada and rest of North America), Europe (France, Germany, Italy, Spain, UK and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific), Latin America (Brazil and rest of Latin America), Middle East and North Africa (Israel and rest of Middle East and North Africa) and rest of the world (South Africa and Rest of the World).
  • A comprehensive assessment of proteomics solution providers is presented, providing in-depth information on various key parameters. This includes the year of establishment, company size (measured by employee count), and location of headquarters (region and country). Additionally, the report provides details on the type of offering provided by each company, including instruments/technologies, kits and reagents, and proteomics services. The assessment also covers the specific type of instrument or technology involved, such as spectrometry, chromatography, electrophoresis, protein microarray, X-ray crystallography, surface plasmon resonance, and other technologies. Furthermore, the report examines the type of solution offered by each company, including core proteomics solutions and bioinformatics solutions. Finally, the assessment focuses on the application area of each company's offerings, including research and clinical diagnostics.
  • A comprehensive competitiveness analysis is conducted to evaluate the strengths and weaknesses of proteomics solution providers. This analysis is based on several key parameters, including developer strength, which is measured by the number of years of experience of a company and its company size. Additionally, the report examines portfolio diversity, encompassing the number of types of offerings, solutions offered, and application areas served. The competitiveness analysis provides a detailed assessment of the competitive landscape, highlighting the unique strengths and focus areas of each company. Furthermore, the report presents a benchmarking analysis, comparing the existing capabilities of these companies against their competitors, to identify areas of differentiation and potential opportunities for growth. This in-depth analysis enables stakeholders to gain a deeper understanding of the competitive dynamics within the proteomics industry and make informed decisions about their strategic directions.
  • Comprehensive profiles of leading players in the proteomics market. Each profile features a brief overview of the company (including information on year of establishment, location of headquarters, number of employees, management team, contact details and business segments), proteomics-related offerings, financial information, recent developments and an informed future outlook.
  • A comprehensive qualitative assessment of the several megatrends ongoing in the proteomics industry, including the advancements in novel mass spectrometers, development of bioinformatics tools and big data, label-free quantification techniques, incorporation of artificial intelligence and machine leaning, integration with multi-omics, emergence of single cell proteomics and proteogenomics, applications in precision medicine, and the evolving regulatory guidelines.
  • A comprehensive value chain analysis is conducted to examine the various stakeholders involved in the proteomics process, encompassing the entire spectrum from suppliers to end-users. This examination provides a detailed understanding of the complex relationships and interactions that shape the proteomics industry.

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the Proteomics Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

  • Agilent
  • Allele Life Sciences
  • Bertis
  • BGI Genomics
  • Bio-Rad Laboratories
  • Bruker Corporation
  • CellCarta
  • Creative Biolabs
  • Creative proteomics
  • Cytiva
  • Macrogen
  • Merck
  • Nautilus
  • Olink
  • PerkinElmer
  • Promega
  • Promise Proteomics
  • Proteome Factory
  • Proteome Sciences
  • Proteomics International

SCIEX

  • Seer
  • SomaLogic
  • Thermo Fisher Scientific
  • VProteomics

TABLE OF CONTENTS

1. RESEARCH METHODOLOGY

  • 1.1. Chapter Overview
  • 1.2. Research Assumptions
  • 1.3. Project Methodology
  • 1.4. Forecast Methodology
  • 1.5. Robust Quality Control
  • 1.6. Key Market Segmentations
  • 1.7. Key Considerations
    • 1.7.1. Demographics
    • 1.7.2. Economic Factors
    • 1.7.3. Government Regulations
    • 1.7.4. Supply Chain
    • 1.7.5. COVID Impact
    • 1.7.6. Market Access
    • 1.7.7. Healthcare Policies
    • 1.7.8. Industry Consolidation

2. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS

  • 2.1. Chapter Overview
  • 2.2. Market Dynamics
    • 2.2.1. Time Period
      • 2.2.1.1. Historical Trends
      • 2.2.1.2. Current and Forecasted Estimates
    • 2.2.2. Currency Coverage and Foreign Exchange Rate
      • 2.2.2.1. Major Currencies Affecting the Market
      • 2.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
      • 2.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
      • 2.2.2.4. Strategies For Mitigating Foreign Exchange Risk
    • 2.2.3. Trade Policies
      • 2.2.3.1. Impact of Trade Barriers on the Market
      • 2.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
    • 2.2.4. Recession
      • 2.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
      • 2.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
    • 2.2.5. Inflation
      • 2.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
      • 2.2.5.2. Potential Impact of Inflation on the Market Evolution

3. EXECUTIVE SUMMARY

4. INTRODUCTION

  • 4.1. An Overview of Proteomics
  • 4.2. Steps involved in Proteomics Process
  • 4.3. Types of Proteomics
  • 4.4. Applications of Proteomics
  • 4.5. Challenges in Proteomics Domain
  • 4.6. Recent Trends in Proteomics Domain

5. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES

  • 5.1. Market Drivers
  • 5.2. Market Restraints
  • 5.3. Market Opportunities
  • 5.4. Market Challenges

6. GLOBAL PROTEOMICS MARKET

  • 6.1. Key Assumptions and Methodology
  • 6.2. Global Proteomics Market, till 2035
    • 6.2.1. Scenario Analysis
      • 6.2.1.1. Conservative Scenario
      • 6.2.1.2. Optimistic Scenario

7. PROTEOMICS MARKET, BY TYPE OF OFFERING

  • 7.1. Key Assumptions and Methodology
  • 7.2. Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035
    • 7.2.1. Proteomics Market for Instruments / Technologies, till 2035
    • 7.2.2. Proteomics Market for Kits and Reagents, till 2035
    • 7.2.3. Proteomics Market for Proteomics Services, till 2035

8. PROTEOMICS MARKET, BY TYPE OF INSTRUMENT / TECHNOLOGY

  • 8.1. Key Assumptions and Methodology
  • 8.2. Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035
    • 8.2.1. Proteomics Market for Chromatography, till 2035
      • 8.2.1.1. Proteomics Market for Affinity Chromatography, till 2035
      • 8.2.1.2. Proteomics Market for High Performance Liquid Chromatography, till 2035
      • 8.2.1.3. Proteomics Market for Ion Chromatography, till 2035
      • 8.2.1.4. Proteomics Market for Supercritical Fluid Chromatography, till 2035
    • 8.2.2. Proteomics Market for Electrophoresis, till 2035
      • 8.2.2.1. Proteomics Market for Proteomics Market for Capillary Electrophoresis, till 2035
      • 8.2.2.2. Proteomics Market for Proteomics Market for Gel Electrophoresis, till 2035
    • 8.2.3. Proteomics Market for Protein Microarrays, till 2035
      • 8.2.3.1. Proteomics Market for Microarrays, till 2035
      • 8.2.3.2. Proteomics Market for Microchips, till 2035
    • 8.2.4. Proteomics Market for Spectrometry, till 2035
      • 8.2.4.1. Proteomics Market for Circular Dichroism, till 2035
      • 8.2.4.2. Proteomics Market for Mass Spectroscopy, till 2035
      • 8.2.4.3. Proteomics Market for Nuclear Magnetic Resonance, till 2035
    • 8.2.5. Proteomics Market for Surface Plasmon Resonance, till 2035
    • 8.2.6. Proteomics Market for X-ray Crystallography, till 2035
    • 8.2.7. Proteomics Market for Other Technologies, till 2035

9. PROTEOMICS MARKET, BY TYPE OF KIT AND REAGENT

  • 9.1. Key Assumptions and Methodology
  • 9.2. Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035
    • 9.2.1. Proteomics Market for Chromatography Reagents, till 2035
    • 9.2.2. Proteomics Market for Electrophoresis Reagents, till 2035
    • 9.2.3. Proteomics Market for Immunoassay Reagents, till 2035
    • 9.2.4. Proteomics Market for Protein Microarray Reagents, till 2035
    • 9.2.5. Proteomics Market for X-ray Crystallography Reagents, till 2035
    • 9.2.6. Proteomics Market for Other Reagents, till 2035

10. PROTEOMICS MARKET, BY TYPE OF PROTEOMICS SERVICE

  • 10.1. Key Assumptions and Methodology
  • 10.2. Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035
    • 10.2.1. Proteomics Market for Bioinformatics Services, till 2035
    • 10.2.2. Proteomics Market for Core Proteomics Services, till 2035

11. PROTEOMICS MARKET, BY APPLICATION AREA

  • 11.1. Key Assumptions and Methodology
  • 11.2. Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035
    • 11.2.1. Proteomics Market for Diagnostics, till 2035
    • 11.2.2. Proteomics Market for Research: Till 2035
      • 11.2.2.1 Proteomics Market for Basic and Translational Research, till 2035
      • 11.2.2.2. Proteomics Market for Drug Discovery, till 2035
    • 11.2.3. Proteomics Market for Other Applications, till 2035

12. PROTEOMICS MARKET, BY END USER

  • 12.1. Key Assumptions and Methodology
  • 12.2. Proteomics Market: Distribution by Type of End User, 2020, 2024 and 2035
    • 12.2.1. Proteomics Market for Academic and Research Institutes, till 2035
    • 12.2.2. Proteomics Market for Clinical Laboratories and Hospitals, till 2035
    • 12.2.3. Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035
    • 12.2.4. Proteomics Market for Other End Users, till 2035

13. PROTEOMICS MARKET, BY GEOGRAPHY

  • 13.1. Key Assumptions and Methodology
  • 13.2. Proteomics Market: Distribution by Geography, 2020, 2024 and 2035
    • 13.2.1. Proteomics Market in North America, till 2035
      • 13.2.1.1. Proteomics Market in the US, till2035
      • 13.2.1.2. Proteomics Market in Canada, till2035
      • 13.2.1.3. Proteomics Market in Rest of North America, till2035
    • 13.2.2. Proteomics Market in Europe, till2035
      • 13.2.2.1. Proteomics Market in Germany, till2035
      • 13.2.2.2. Proteomics Market in France, till2035
      • 13.2.2.3. Proteomics Market in the UK, till 2035
      • 13.2.2.4. Proteomics Market in Italy, till 2035
      • 13.2.2.5. Proteomics Market in Spain, till 2035
      • 13.2.2.6. Proteomics Market in Rest of Europe, till 2035
    • 13.2.3. Proteomics Market in Asia-Pacific, till 2035
      • 13.2.3.1. Proteomics Market in South Korea, till 2035
      • 13.2.3.2. Proteomics Market in China, till 2035
      • 13.2.3.3. Proteomics Market in Japan, till 2035
      • 13.2.3.4. Proteomics Market in India, till 2035
      • 13.2.3.5. Proteomics Market in Rest of Asia-Pacific, till 2035
    • 13.2.4. Proteomics Market in Latin America, till 2035
      • 13.2.4.1. Proteomics Market in Brazil, till 2035
      • 13.2.4.2. Proteomics Market in Rest of Latin America, till 2035
    • 13.2.5. Proteomics Market in Middle East and North Africa, till 2035
      • 13.2.5.1. Proteomics Market in Israel, till 2035
      • 13.2.5.2. Proteomics Market in Rest of Middle East and North Africa, till 2035
    • 13.2.6. Proteomics Market in Rest of the World, till 2035
      • 13.2.6.1. Proteomics Market in South Africa, till 2035
      • 13.2.6.2. Proteomics Market in Other Countries, till 2035

14. MARKET LANDSCAPE: KEY PROTEOMICS SOLUTION PROVIDERS

  • 14.1. Key Proteomics Solution Providers: Overall Market Landscape
    • 14.1.1. Analysis by Year of Establishment
    • 14.1.2. Analysis by Company Size
    • 14.1.3. Analysis by Location of Headquarters (Region)
    • 14.1.4. Analysis by Location of Headquarters (Country)
    • 14.1.5. Analysis by Type of Offering
    • 14.1.6. Analysis by Type of Instrument / Technology Involved
    • 14.1.7. Analysis by Type of Solution Offered
    • 14.1.8. Analysis by Application Area

15. COMPANY COMPETITIVENESS ANALYSIS: KEY PROTEOMICS SOLUTION PROVIDERS

  • 15.1. Key Parameters and Methodology
  • 15.2. Company Competitiveness Analysis: Key Proteomics Solution Providers
  • 15.3. Benchmarking Analysis of Key Proteomics Solution Providers
    • 15.3.1. Spider Web Analysis: Benchmarking of Key Players
    • 15.3.2. Parameter-wise Benchmarking of Proteomics Solution Providers
      • 15.3.2.1. By Years of Experience
      • 15.3.2.2. By Company Size
      • 15.3.2.3. By Application Area
      • 15.3.2.4. By Number of Offerings
      • 15.3.2.5. By Number of Instruments / Technologies
      • 15.3.2.6. By Number of Solutions Offered

16. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN NORTH AMERICA

  • 16.1. Agilent Technologies
    • 16.1.1. Company Details
    • 16.1.2. Proteomics-related Offerings
    • 16.1.3. Financial Details
    • 16.1.4. Recent Developments and Future Outlook
  • 16.2. Bruker
  • 16.3. Creative Biolabs
  • 16.4. Nautilus Biotechnology
  • 16.5. PerkinElmer
  • 16.6. Seer
  • 16.7. Thermo Fisher Scientific
  • 16.8. Bio - Rad Laboratories
  • 16.9. CellCarta
  • 16.10. Creative Proteomics
  • 16.11. Cytiva
  • 16.12. Promega
  • 16.13. SCIEX
  • 16.14. SomaLogic
  • 16.15. Key Winning Strategies

17. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN EUROPE

  • 17.1. Merck
    • 17.1.1. Company Details
    • 17.1.2. Proteomics-related Offerings
    • 17.1.3. Financial Details
    • 17.1.4. Recent Developments and Future Outlook
  • 17.2. Olink
  • 17.3. Promise Proteomics
  • 17.4. Proteome Factory
  • 17.5. Proteome Sciences
  • 17.6. Key Winning Strategies

18. COMPANY PROFILES: PROTEOMICS SOLUTION PROVIDERS HEADQUARTERED IN ASIA-PACIFIC

  • 18.1. Proteomics International
    • 18.1.1. Company Details
    • 18.1.2. Proteomics-related Offerings
    • 18.1.3. Financial Details
    • 18.1.4. Recent Developments and Future Outlook
  • 18.2. Macrogen
  • 18.3. Allele Life Sciences
  • 18.4. Bertis
  • 18.5. BGI Genomics
  • 18.6. VProteomics
  • 18.7. Key Winning Strategies

19. PROTEOMICS MARKET: MEGATRENDS ANALYSIS

  • 19.1. Megatrends in the Proteomics Market
    • 19.1.1. Advancements of Novel Mass Spectrometers
    • 19.1.2. Development of Bioinformatics Tools and Big Data
    • 19.1.3. Label-free Quantification Techniques
    • 19.1.4. Adoption of Artificial Intelligence and Machine Leaning
    • 19.1.5. Integration of Multi-omics
    • 19.1.6. Emergence of Single Cell Proteomics and Proteogenomics
    • 19.1.7. Applications in Precision Medicine
    • 19.1.8. Evolving Regulatory Guidelines

20. VALUE CHAIN ANALYSIS

21. EXECUTIVE INSIGHTS

22. APPENDIX 1: TABULATED DATA

23. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

  • Table 14.1 List of Key Proteomics Solution Providers
  • Table 14.2 Key Proteomics Solution Providers: Information on Type of Offering and Type of Instrument / Technology Involved
  • Table 14.3 Key Proteomics Solution Providers: Information on Type of Solution Offered and Application Area
  • Table 22.1 Global Proteomics Market, till 2035 (USD Billion)
  • Table 22.2 Global Proteomics Market, till 2035: Conservative Scenario (USD Billion)
  • Table 22.3 Global Proteomics Market, till 2035: Optimistic Scenario (USD Billion)
  • Table 22.4 Global Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035 (USD Million)
  • Table 22.5 Proteomics Market for Instruments / Technologies, till 2035 (USD Million)
  • Table 22.6 Proteomics Market for Kits and Reagents, till 2035 (USD Million)
  • Table 22.7 Proteomics Market for Proteomics Services, till 2035 (USD Million)
  • Table 22.8 Global Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035 (USD Million)
  • Table 22.9 Proteomics Market for Chromatography, till 2035 (USD Million)
  • Table 22.10 Proteomics Market for Affinity Chromatography, till 2035 (USD Million)
  • Table 22.11 Proteomics Market for High Performance Liquid Chromatography, till 2035 (USD Million)
  • Table 22.12 Proteomics Market for Ion Chromatography, till 2035 (USD Million)
  • Table 22.13 Proteomics Market for Supercritical Fluid Chromatography, till 2035 (USD Million)
  • Table 22.14 Proteomics Market for Electrophoresis, till 2035 (USD Million)
  • Table 22.15 Proteomics Market for Capillary Electrophoresis, till 2035 (USD Million)
  • Table 22.16 Proteomics Market for Gel Electrophoresis, till 2035 (USD Million)
  • Table 22.17 Proteomics Market for Protein Microarrays, till 2035 (USD Million)
  • Table 22.18 Proteomics Market for Microarrays, till 2035 (USD Million)
  • Table 22.19 Proteomics Market for Microchips, till 2035 (USD Million)
  • Table 22.20 Proteomics Market for Spectrometry, till 2035 (USD Million)
  • Table 22.21 Proteomics Market for Circular Dichroism, till 2035 (USD Million)
  • Table 22.22 Proteomics Market for Mass Spectroscopy, till 2035 (USD Million)
  • Table 22.23 Proteomics Market for Nuclear Magnetic Resonance, till 2035 (USD Million)
  • Table 22.24 Proteomics Market for Surface Plasmon Resonance, till 2035 (USD Million)
  • Table 22.25 Proteomics Market for X-ray Crystallography, till 2035 (USD Million)
  • Table 22.26 Proteomics Market for Other Technologies, till 2035 (USD Million)
  • Table 22.27 Global Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035 (USD Million)
  • Table 22.28 Proteomics Market for Chromatography Reagents, till 2035 (USD Million)
  • Table 22.29 Proteomics Market for Electrophoresis Reagents, till 2035 (USD Million)
  • Table 22.30 Proteomics Market for Immunoassay Reagents, till 2035 (USD Million)
  • Table 22.31 Proteomics Market for Protein Microarray Reagents, till 2035 (USD Million)
  • Table 22.32 Proteomics Market for X-ray Crystallography Reagents, till 2035 (USD Million)
  • Table 22.33 Proteomics Market for Other Reagents, till 2035(USD Million)
  • Table 22.34 Global Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035 (USD Million)
  • Table 22.35 Proteomics Market for Bioinformatics Services, till 2035 (USD Million)
  • Table 22.36 Proteomics Market for Core Proteomics Services, till 2035 (USD Million)
  • Table 22.37 Global Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)
  • Table 22.38 Proteomics Market for Diagnostics, till 2035 (USD Million)
  • Table 22.39 Proteomics Market for Research, till 2035 (USD Million)
  • Table 22.40 Proteomics Market for Basic and Translational Research, till 2035 (USD Million)
  • Table 22.41 Proteomics Market for Drug Discovery, till 2035 (USD Million)
  • Table 22.42 Proteomics Market for Other Applications, till 2035 (USD Million)
  • Table 22.43 Global Proteomics Market: Distribution by End User, 2020, 2024 and 2035 (USD Million)
  • Table 22.44 Proteomics Market for Academic and Research Institutes, till 2035 (USD Million)
  • Table 22.45 Proteomics Market for Clinical Laboratories and Hospitals, till 2035 (USD Million)
  • Table 22.46 Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035 (USD Million)
  • Table 22.47 Proteomics Market for Other End Users, till 2035 (USD Million)
  • Table 22.48 Global Proteomics Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)
  • Table 22.49 Proteomics Market in North America, till 2035 (USD Million)
  • Table 22.50 Proteomics Market in the US, till 2035 (USD Million)
  • Table 22.51 Proteomics Market in Canada, till 2035 (USD Million)
  • Table 22.52 Proteomics Market in Rest of North America, till 2035 (USD Million)
  • Table 22.53 Proteomics Market in Europe, till 2035 (USD Million)
  • Table 22.54 Proteomics Market in Germany, till 2035 (USD Million)
  • Table 22.55 Proteomics Market in France, till 2035 (USD Million)
  • Table 22.56 Proteomics Market in the UK, till 2035 (USD Million)
  • Table 22.57 Proteomics Market in Italy, till 2035 (USD Million)
  • Table 22.58 Proteomics Market in Spain, till 2035 (USD Million)
  • Table 22.59 Proteomics Market in Rest of Europe, till 2035 (USD Million)
  • Table 22.60 Proteomics Market in Asia-Pacific, till 2035 (USD Million)
  • Table 22.61 Proteomics Market in South Korea, till 2035 (USD Million)
  • Table 22.62 Proteomics Market in China, till 2035 (USD Million)
  • Table 22.63 Proteomics Market in Japan, till 2035 (USD Million)
  • Table 22.64 Proteomics Market in India, till 2035 (USD Million)
  • Table 22.65 Proteomics Market in Rest of Asia-Pacific, till 2035 (USD Million)
  • Table 22.66 Proteomics Market in Latin America, till 2035 (USD Million)
  • Table 22.67 Proteomics Market in Brazil, till 2035 (USD Million)
  • Table 22.68 Proteomics Market in Rest of Latin America, till 2035 (USD Million)
  • Table 22.69 Proteomics Market in Middle East and North Africa, till 2035 (USD Million)
  • Table 22.70 Proteomics Market in Israel, till 2035 (USD Million)
  • Table 22.71 Proteomics Market in Rest of Middle East and North Africa, till 2035 (USD Million)
  • Table 22.72 Proteomics Market in Rest of the World, till 2035 (USD Million)
  • Table 22.73 Proteomics Market in South Africa, till 2035 (USD Million)
  • Table 22.74 Proteomics Market in Other Countries, till 2035 (USD Million)
  • Table 22.75 Key Proteomics Solution Providers: Distribution by Year of Establishment
  • Table 22.76 Key Proteomics Solution Providers: Distribution by Company Size
  • Table 22.77 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Region)
  • Table 22.78 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Country)
  • Table 22.79 Key Proteomics Solution Providers: Distribution by Type of Offering
  • Table 22.80 Key Proteomics Solution Providers: Distribution by Type of Instrument / Technology
  • Table 22.81 Key Proteomics Solution Providers: Distribution by Type of Solution Offered
  • Table 22.82 Key Proteomics Solution Providers: Distribution by Application Area
  • Table 22.83 Agilent Technologies: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Table 22.84 Bio - Rad Laboratories: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Table 22.85 Bruker: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Table 22.86 PerkinElmer: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Table 22.87 Seer: Annual Revenues, FY 2021-FY 2023 (USD Million)
  • Table 22.88 Thermo Fisher Scientific: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Table 22.89 Merck: Annual Revenues, FY 2021-FY 2023 (EUR Billion)
  • Table 22.90 Olink: Annual Revenues, FY 2021-FY 2023 (USD Million)
  • Table 22.91 Proteomics International: Annual Revenues, FY 2021-FY 2023 (USD Million)

List of Figures

  • Figure 1.1 Research Methodology: Research Assumptions
  • Figure 1.2 Research Methodology: Project Methodology
  • Figure 1.3 Research Methodology: Forecast Methodology
  • Figure 1.4 Research Methodology: Robust Quality Control
  • Figure 1.5 Research Methodology: Key Market Segmentations
  • Figure 3.1 Executive Summary: Market Sizing and Opportunity Analysis
  • Figure 3.2 Executive Summary: Market Landscape of Key Proteomics Solution Providers
  • Figure 4.1 Steps involved in Proteomics Process
  • Figure 6.1 Global Proteomics Market, till 2035 (USD Billion)
  • Figure 6.2 Global Proteomics Market, till 2035: Conservative Scenario (USD Billion)
  • Figure 6.3 Global Proteomics Market, till 2035: Optimistic Scenario (USD Billion)
  • Figure 6.4 Global Proteomics Market: Distribution by Type of Offering, 2020, 2024 and 2035 (USD Million)
  • Figure 7.2 Proteomics Market for Instruments / Technologies, till 2035 (USD Million)
  • Figure 7.3 Proteomics Market for Kits and Reagents, till 2035 (USD Million)
  • Figure 7.4 Proteomics Market for Proteomics Services, till 2035 (USD Million)
  • Figure 8.1 Global Proteomics Market: Distribution by Type of Instrument / Technology, 2020, 2024 and 2035 (USD Million)
  • Figure 8.2 Proteomics Market for Chromatography, till 2035 (USD Million)
  • Figure 8.3 Proteomics Market for Affinity Chromatography, till 2035 (USD Million)
  • Figure 8.4 Proteomics Market for High Performance Liquid Chromatography, till 2035 (USD Million)
  • Figure 8.5 Proteomics Market for Ion Chromatography, till 2035 (USD Million)
  • Figure 8.6 Proteomics Market for Supercritical Fluid Chromatography, till 2035 (USD Million)
  • Figure 8.7 Proteomics Market for Electrophoresis, till 2035 (USD Million)
  • Figure 8.8 Proteomics Market for Capillary Electrophoresis, till 2035 (USD Million)
  • Figure 8.9 Proteomics Market for Gel Electrophoresis, till 2035 (USD Million)
  • Figure 8.10 Proteomics Market for Protein Microarrays, till 2035 (USD Million)
  • Figure 8.11 Proteomics Market for Microarrays, till 2035 (USD Million)
  • Figure 8.12 Proteomics Market for Microchips, till 2035 (USD Million)
  • Figure 8.13 Proteomics Market for Spectrometry, till 2035 (USD Million)
  • Figure 8.14 Proteomics Market for Circular Dichroism, till 2035 (USD Million)
  • Figure 8.15 Proteomics Market for Mass Spectroscopy, till 2035 (USD Million)
  • Figure 8.16 Proteomics Market for Nuclear Magnetic Resonance, till 2035 (USD Million)
  • Figure 8.17 Proteomics Market for Surface Plasmon Resonance, till 2035 (USD Million)
  • Figure 8.18 Proteomics Market for X-ray Crystallography, till 2035 (USD Million)
  • Figure 8.19 Proteomics Market for Other Technologies, till 2035 (USD Million)
  • Figure 9.1 Global Proteomics Market: Distribution by Type of Kit and Reagent, 2020, 2024 and 2035 (USD Million)
  • Figure 9.2 Proteomics Market for Chromatography Reagents, till 2035 (USD Million)
  • Figure 9.3 Proteomics Market for Electrophoresis Reagents, till 2035 (USD Million)
  • Figure 9.4 Proteomics Market for Immunoassay Reagents, till 2035 (USD Million)
  • Figure 9.5 Proteomics Market for Protein Microarray Reagents, till 2035 (USD Million)
  • Figure 9.6 Proteomics Market for X-ray Crystallography Reagents, till 2035 (USD Million)
  • Figure 9.7 Proteomics Market for Other Reagents, till 2035 (USD Million)
  • Figure 10.1 Global Proteomics Market: Distribution by Type of Proteomics Service, 2020, 2024 and 2035 (USD Million)
  • Figure 10.2 Proteomics Market for Bioinformatics Services, till 2035 (USD Million)
  • Figure 10.3 Proteomics Market for Core Proteomics Services, till 2035 (USD Million)
  • Figure 11.1 Global Proteomics Market: Distribution by Application Area, 2020, 2024 and 2035 (USD Million)
  • Figure 11.2 Proteomics Market for Diagnostics, till 2035 (USD Million)
  • Figure 11.3 Proteomics Market for Research, till 2035 (USD Million)
  • Figure 11.4 Proteomics Market for Basic and Translational Research, till 2035 (USD Million)
  • Figure 11.5 Proteomics Market for Drug Discovery, till 2035 (USD Million)
  • Figure 11.6 Proteomics Market for Other Applications, till 2035 (USD Million)
  • Figure 12.1 Global Proteomics Market: Distribution by End User, 2020, 2024 and 2035 (USD Million)
  • Figure 12.2 Proteomics Market for Academic and Research Institutes, till 2035 (USD Million)
  • Figure 12.3 Proteomics Market for Clinical Laboratories and Hospitals, till 2035 (USD Million)
  • Figure 12.4 Proteomics Market for Pharmaceutical / Biotechnology Companies, till 2035 (USD Million)
  • Figure 12.5 Proteomics Market for Other End Users, till 2035 (USD Million)
  • Figure 13.1 Global Proteomics Market: Distribution by Geography, 2020, 2024 and 2035 (USD Million)
  • Figure 13.2 Proteomics Market in North America, till 2035 (USD Million)
  • Figure 13.3 Proteomics Market in the US, till 2035 (USD Million)
  • Figure 13.4 Proteomics Market in Canada, till 2035 (USD Million)
  • Figure 13.5 Proteomics Market in Rest of North America, till 2035 (USD Million)
  • Figure 13.6 Proteomics Market in Europe, till 2035 (USD Million)
  • Figure 13.7 Proteomics Market in Germany, till 2035 (USD Million)
  • Figure 13.8 Proteomics Market in France, till 2035 (USD Million)
  • Figure 13.9 Proteomics Market in the UK, till 2035 (USD Million)
  • Figure 13.10 Proteomics Market in Italy, till 2035 (USD Million)
  • Figure 13.11 Proteomics Market in Spain, till 2035 (USD Million)
  • Figure 13.12 Proteomics Market in Rest of Europe, till 2035 (USD Million)
  • Figure 13.13 Proteomics Market in Asia-Pacific, till 2035 (USD Million)
  • Figure 13.14 Proteomics Market in South Korea, till 2035 (USD Million)
  • Figure 13.15 Proteomics Market in China, till 2035 (USD Million)
  • Figure 13.16 Proteomics Market in Japan, till 2035 (USD Million)
  • Figure 13.17 Proteomics Market in India, till 2035 (USD Million)
  • Figure 13.18 Proteomics Market in Rest of Asia-Pacific, till 2035 (USD Million)
  • Figure 13.19 Proteomics Market in Latin America, till 2035 (USD Million)
  • Figure 13.20 Proteomics Market in Brazil, till 2035 (USD Million)
  • Figure 13.21 Proteomics Market in Rest of Latin America, till 2035 (USD Million)
  • Figure 13.22 Proteomics Market in Middle East and North Africa, till 2035 (USD Million)
  • Figure 13.23 Proteomics Market in Israel, till 2035 (USD Million)
  • Figure 13.24 Proteomics Market in Rest of Middle East and North Africa, till 2035 (USD Million)
  • Figure 13.25 Proteomics Market in Rest of the World, till 2035 (USD Million)
  • Figure 13.26 Proteomics Market in South Africa, till 2035 (USD Million)
  • Figure 13.27 Proteomics Market in Other Countries, till 2035 (USD Million)
  • Figure 14.1 Key Proteomics Solution Providers: Distribution by Year of Establishment
  • Figure 14.2 Key Proteomics Solution Providers: Distribution by Company Size
  • Figure 14.3 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Region)
  • Figure 14.4 Key Proteomics Solution Providers: Distribution by Location of Headquarters (Country)
  • Figure 14.5 Key Proteomics: Distribution by Type of Offering
  • Figure 14.6 Key Proteomics: Distribution by Type of Instrument / Technology
  • Figure 14.7 Key Proteomics: Distribution by Type of Solution Offered
  • Figure 14.8 Key Proteomics: Distribution by Application Area
  • Figure 15.1 Key Proteomics Solution Providers: 3-D Bubble Chart
  • Figure 15.2 Spider Web Analysis: Agilent Technologies
  • Figure 15.3 Spider Web Analysis: Bruker
  • Figure 15.4 Spider Web Analysis: CellCarta
  • Figure 15.5 Spider Web Analysis: Creative Biolabs
  • Figure 15.6 Spider Web Analysis: Creative Proteomics
  • Figure 15.7 Spider Web Analysis: Olink
  • Figure 15.8 Spider Web Analysis: SCIEX
  • Figure 15.9 Spider Web Analysis: SomaLogic
  • Figure 15.10 Spider Web Analysis: Bertis
  • Figure 15.11 Spider Web Analysis: Bio - Rad Laboratories
  • Figure 15.12 Parameter-wise Benchmarking: By Years of Experience
  • Figure 15.13 Parameter-wise Benchmarking: By Company Size
  • Figure 15.14 Parameter-wise Benchmarking: By Application Area
  • Figure 15.15 Parameter-wise Benchmarking: By Number of Offerings
  • Figure 15.16 Parameter-wise Benchmarking: By Number of Instruments / Technologies
  • Figure 15.17 Parameter-wise Benchmarking: By Number of Solutions Offered
  • Figure 16.1 Agilent Technologies: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Figure 16.2 Bio - Rad Laboratories: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Figure 16.3 Bruker: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Figure 16.4 PerkinElmer: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Figure 16.5 Seer: Annual Revenues, FY 2021-FY 2023 (USD Million)
  • Figure 16.6 Thermo Fisher Scientific: Annual Revenues, FY 2021-FY 2023 (USD Billion)
  • Figure 17.1 Merck: Annual Revenues, FY 2021-FY 2023 (EUR Billion)
  • Figure 17.2 Olink: Annual Revenues, FY 2021-FY 2023 (USD Million)
  • Figure 18.1 Proteomics International: Annual Revenues, FY 2021-FY 2023 (USD Million)